.jpg)
Ablatotech Biotherapeutics Company
Revolutionizing healthcare, one breakthrough at a time

Join the Clinical Trial for Nygela Topical Cream
Are you living with psoriasis, eczema, or acne? Ablatotech, a leader in innovative biotherapeutics, is excited to announce a groundbreaking clinical trial for a natural, topical cream designed to redefine how we care for chronic skin conditions. This revolutionary solution aims to be a cost-effective, safer, and more effective alternative to immune-suppressing drugs currently on the market.
​
Our mission is simple: to harness the power of nature and cutting-edge science to deliver relief and improve the lives of those affected by these conditions. As a participant in this study, you will play a vital role in shaping the future of skincare treatments while receiving expert guidance and support throughout the trial.
​
Key Details:
-
This study is open to adults aged 18–65 with mild-to-moderate psoriasis, eczema, or acne.
-
Participants will apply the topical cream as directed over a 12-week period.
-
The trial includes regular check-ins with our team to ensure safety and monitor progress.
Why Join?
-
Be part of an innovative effort to transform skincare therapies.
-
Gain access to cutting-edge, natural treatments at no cost.
-
Help advance science and improve options for millions worldwide.
📅 Enrollment is now open, but spaces are limited! Be a part of this healthcare revolution today. Use the form below to sign up now!